The failure of a clinical trial on Alzheimer's leaves families and patients heartbroken



[ad_1]

Although recent experimental treatments have not produced new drugs, they have nevertheless helped researchers to learn more about the brain and the disease, Snyder said. Scientists are beginning to understand that a person 's brain begins to change about ten years before Alzheimer' s disease is diagnosed.

"We are absolutely committed to ensuring that nothing is left to chance and that all tracks are continued," said Snyder. "We are optimistic because as our understanding of science continues to grow and move forward, our ability to target different biologies while combining some of these data is growing."

The Borghoffs convened a family reunion on Thursday night. Jeff, positive as always, said he wanted to find another clinical trial that he could participate in to help scientists find a cure or cure that would help his children or grandchildren. children.

Kim asks her to try marijuana for medical purposes or CBD oil. She hopes these options could allay the anxiety and anger that Jeff is experimenting with more and more. However, neither the FDA has approved the treatment or management of Alzheimer's disease or other dementias, nor has it been evaluated in clinical trials. It is also difficult to know how people with dementia would react to the psychoactive effects of marijuana or how it would interact with other drugs used to treat the disease.

"I'm always looking at all possibilities and angles, I'm convinced that a box has six faces and that I can only see three faces at a time," said Jeff Borghoff. "There are other perspectives to consider and other elements to consider."

[ad_2]
Source link